Noticeably, inhibiting c-Met kinase we were able to interfere with migratory activity and acquisition of metastatic signature of co-cultured breast cancer cells (Figure 6A), and significantly reduce HGF expression, as well (Figure 6B). Here, HGF is linked to breast carcinoma.